Dr. Rotenberg is named 2025 Harrington Scholar-Innovator Award recipient.
Congratulations to Alexander Rotenberg, MD, PhD. for being named one of ten 2025 Harrington Scholar-Innovator Award recipient by the Harrington Discovery Institute, for his project titled ‘Gene therapy for a rare inherited disease, Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)’.Dr. Rotenberg is the Director of the Neuromodulation Program at Boston Children’s Hospital…
Read MoreCelebrating Rare Disease Day
Wisconsin mother creates SSADH Association after her son is diagnosed with neuro disorder. Spectrum News Wisconsin | BY Abbey Taylor | PUBLISHED 12:59 PM ET Feb. 26, 2025 OCONOMOWOC, Wis. — A mother of three, Carolyn Hoffman said her 30-year-old middle child, Sam, was an easy baby to raise. “Sam was the…
Read MoreDr. Lee’s Podcast on Gene Therapy for SSADH Deficiency
Dr. Henry Lee, Ph.D., Boston Children’s Hospital, F.M. Kirby Neurobiology Center joins the Journal of Inherited Metabolic Disease (JIMD) podcast. Dr. Lee discusses the challenges of developing gene therapies for inherited disorders of neurotransmission. Additionally he shares the progress that his group has made with succinic semialdehyde dehydrogenase (SSADH) deficiency.…
Read MoreSSADHD Presentation at PAME
Charity Adams (Mom to Bond), Dr. Phil Pearl and Dr. Itay Tokatly Latz spoke at the 2024 PAME (Partners Against Morality in Epilepsy) event on December 5th in Los Angeles, CA. Charity spoke of the ground breaking work that Bond (pictured below) participated in just months before his passing, during…
Read MoreNatural History Study Expanded to 10 Years
We are thrilled to announce that the grant for the SSADH Deficiency Natural History Study was renewed by the National Institutes of Health (NIH) to allow collection of more data over the next five years to increase our understanding of the disorder. This will also allow for us to be…
Read MoreSSADHD: a metabolic and genomic approach to diagnosis
Genomic sequencing offers an untargeted, data-driven approach to genetic diagnosis; however, variants of uncertain significance often hinder the diagnostic process. The discovery of rare genomic variants without previously known functional evidence of pathogenicity often results in variants being overlooked as potentially causative, particularly in individuals with undifferentiated phenotypes. Consequently, many…
Read More